(Reuters) – Novavax’s updated vaccine has been granted World Health Organization’s (WHO) emergency-use authorization for active immunization to prevent COVID-19 in individuals aged 12 and older.
(Reporting by Pratik Jain in Bengaluru; Editing by Krishna Chandra Eluri)
